Literature DB >> 11582517

Autonomic nervous system innervation of lymphoid territories in spleen: a possible involvement of noradrenergic neurons for prion neuroinvasion in natural scrapie.

A Bencsik1, S Lezmi, T Baron.   

Abstract

In experimental as well as in natural scrapie, transmissible spongiform encephalopathies (TSEs), the infectious agent, closely related to PrPsc, an abnormal isoform of the cellular prion protein, invades and replicates in lymphoid organs such as spleen before affecting the brain. To clarify the cellular requirements for the possible neuroinvasion of scrapie agent from the spleen to the central nervous system, we have studied the sympathetic innervation within the lymphoid territories of the spleen. These noradrenergic fibers originating from the coeliomesenteric ganglia were examined with regard to PrPsc-associated cells in spleen of adult sheep severely affected with natural scrapie. Using a double immunolabelling strategy, we demonstrated the proximity of noradrenergic endings with PrPsc-accumulating cells, strengthening its possible implication in the neuroinvasion process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11582517     DOI: 10.1080/135502801753170309

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  39 in total

1.  Genetic susceptibility and transmission factors in scrapie: detailed analysis of an epidemic in a closed flock of Romanov.

Authors:  J M Elsen; Y Amigues; F Schelcher; V Ducrocq; O Andreoletti; F Eychenne; J V Khang; J P Poivey; F Lantier; J L Laplanche
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

2.  Follicular dendritic cells in TSE pathogenesis.

Authors:  M E Bruce; K L Brown; N A Mabbott; C F Farquhar; M Jeffrey
Journal:  Immunol Today       Date:  2000-09

3.  Preclinical detection of PrPSc in nictitating membrane lymphoid tissue of sheep.

Authors:  K I O'Rourke; T V Baszler; S M Parish; D P Knowles
Journal:  Vet Rec       Date:  1998-05-02       Impact factor: 2.695

4.  Immunohistochemical detection of prion protein in lymphoid tissues of sheep with natural scrapie.

Authors:  L J van Keulen; B E Schreuder; R H Meloen; G Mooij-Harkes; M E Vromans; J P Langeveld
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

5.  Pathogenesis of scrapie in the mouse: the role of the spleen.

Authors:  H Fraser; A G Dickinson
Journal:  Nature       Date:  1970-05-02       Impact factor: 49.962

6.  Evidence for an alternative direct route of access for the scrapie agent to the brain bypassing the spinal cord.

Authors:  E Baldauf; M Beekes; H Diringer
Journal:  J Gen Virol       Date:  1997-05       Impact factor: 3.891

7.  Pathogenesis of mouse scrapie. Evidence for direct neural spread of infection to the CNS after injection of sciatic nerve.

Authors:  R H Kimberlin; S M Hall; C A Walker
Journal:  J Neurol Sci       Date:  1983 Oct-Nov       Impact factor: 3.181

8.  Scrapie infectivity and proteinase K-resistant prion protein in sheep placenta, brain, spleen, and lymph node: implications for transmission and antemortem diagnosis.

Authors:  R Race; A Jenny; D Sutton
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226

9.  Natural infection of Suffolk sheep with scrapie virus.

Authors:  W J Hadlow; R C Kennedy; R E Race
Journal:  J Infect Dis       Date:  1982-11       Impact factor: 5.226

10.  Close vicinity of PrP expressing cells (FDC) with noradrenergic fibers in healthy sheep spleen.

Authors:  A Bencsik; S Lezmi; G Hunsmann; T Baron
Journal:  Dev Immunol       Date:  2001
View more
  11 in total

1.  First case of feline spongiform encephalopathy in a captive cheetah born in France: PrP(sc) analysis in various tissues revealed unexpected targeting of kidney and adrenal gland.

Authors:  Stephane Lezmi; Anna Bencsik; Eoin Monks; Thierry Petit; Thierry Baron
Journal:  Histochem Cell Biol       Date:  2003-05-01       Impact factor: 4.304

2.  Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations.

Authors:  Carole Crozet; Yea-Lih Lin; Clément Mettling; Chantal Mourton-Gilles; Pierre Corbeau; Sylvain Lehmann; Véronique Perrier
Journal:  J Cell Sci       Date:  2004-10-19       Impact factor: 5.285

Review 3.  Molecular neurology of prion disease.

Authors:  J Collinge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

Review 4.  Prion diseases and the gastrointestinal tract.

Authors:  G A Davies; Adam R Bryant; John D Reynolds; Frank R Jirik; Keith A Sharkey
Journal:  Can J Gastroenterol       Date:  2006-01       Impact factor: 3.522

5.  Neuroinvasion in prion diseases: the roles of ascending neural infection and blood dissemination.

Authors:  Sílvia Sisó; Lorenzo González; Martin Jeffrey
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-06-23

6.  Subclinical prion disease induced by oral inoculation.

Authors:  Alana M Thackray; Michael A Klein; Raymond Bujdoso
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

7.  New insights into early sequential PrPsc accumulation in scrapie infected mouse brain evidenced by the use of streptomycin sulfate.

Authors:  Anna A Bencsik; Edwige Leclere; Hervé Perron; Aly Moussa
Journal:  Histochem Cell Biol       Date:  2008-01-26       Impact factor: 4.304

8.  Neuropathological characterisation of French bovine spongiform encephalopathy cases.

Authors:  Sabine Debeer; Thierry Baron; Anna Bencsik
Journal:  Histochem Cell Biol       Date:  2003-11-18       Impact factor: 4.304

9.  Membrane toxicity of abnormal prion protein in adrenal chromaffin cells of scrapie infected sheep.

Authors:  Gillian McGovern; Martin Jeffrey
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

10.  Scrapie strain transmission studies in ovine PrP transgenic mice reveal dissimilar susceptibility.

Authors:  Anna Bencsik; Sandrine Philippe; Sabine Debeer; Carole Crozet; Didier Calavas; Thierry Baron
Journal:  Histochem Cell Biol       Date:  2007-03-15       Impact factor: 2.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.